SEC 13F Intelligence

Managers / Q1 2026

Slotnik Capital, LLC

CIK 0001963764 · 200 CRESCENT CT., SUITE 530, DALLAS, TX, 75201 · 214-462-9203

Reported Value
$342M
Q1 2026
Positions
27
Filings on Record
10
2019–present window
Filed
May 15, 2026
original filing

Summary

Slotnik Capital, LLC reported $342M in U.S.-listed holdings across 27 positions for Q1 2026.

Its largest position, GTLS, represents 13.4% of the portfolio.

Compared with Q4 2025, the fund opened 16 new positions and exited 19.

Portfolio Metrics

Turnover
+66.6%
vs prior filed quarter
Top-10 Concentration
+70.8%
share of reported value
Largest Position
+13.4%
Chart Inds
New / Exited
16 / 19
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’23: $168MQ4 ’23Q1 ’24: $163MQ2 ’24: $206MQ2 ’24Q3 ’24: $302MQ4 ’24: $221MQ4 ’24Q1 ’25: $207MQ2 ’25: $262MQ2 ’25Q3 ’25: $320MQ4 ’25: $429MQ4 ’25Q1 ’26: $342Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 94.9%MLP: 3.2%REIT: 1.1%Other: 0.9%
  • Common Stock · 94.9% · $324M
  • MLP · 3.2% · $11M
  • REIT · 1.1% · $4M
  • Other · 0.9% · $3M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
MASI*MASIMO CORPNEW+240.3K240.3K+$43M$43M
PENPENUMBRA INCNEW+101.0K101.0K+$33M$33M
430TERNS PHARMACEUTICALS INCNEW+420.7K420.7K+$22M$22M
WBSWEBSTER FINL CORPNEW+272.0K272.0K+$19M$19M
AVOMISSION PRODUCE INCNEW+1.12M1.12M+$15M$15M
SLABSILICON LABORATORIES INCNEW+65.5K65.5K+$14M$14M
ACLXGBXARCELLX INCNEW+118.0K118.0K+$14M$14M
ARISARIS MINING CORPORATIONNEW+700.1K700.1K+$13M$13M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2026

23 positions
#IssuerClass% PortfolioValueShares
1GTLSCHART INDS INChistory →COM13.41%$46M221.8K
2MASI*MASIMO CORPhistory →COM12.50%$43M240.3K
3LBRDALIBERTY BROADBAND CORPCOM SER A · COM SER C9.97%$34M678.5K
4PENPENUMBRA INChistory →COM9.70%$33M101.0K
5430TERNS PHARMACEUTICALS INChistory →COM6.49%$22M420.7K
6WBSWEBSTER FINL CORPhistory →COM5.52%$19M272.0K
7WBDWARNER BROS DISCOVERY INChistory →COM SER A4.73%$16M588.3K
8KVUEKENVUE INChistory →COM4.34%$15M860.2K
9SLABSILICON LABORATORIES INChistory →COM3.99%$14M65.5K
10ACLXGBXARCELLX INChistory →COMMON STOCK3.96%$14M118.0K
11ARISARIS MINING CORPORATIONhistory →COM3.80%$13M700.1K
12T86TRI POINTE HOMES INChistory →COM3.60%$12M263.3K
13WESWESTERN MIDSTREAM PARTNERS Lhistory →COM UNIT LP INT3.16%$11M262.6K
14AVOMISSION PRODUCE INChistory →COM3.08%$11M765.1K
15UNFUNIFIRST CORP MASShistory →COM2.54%$9M34.5K
16APLSUSDAPELLIS PHARMACEUTICALS INChistory →COM1.59%$5M135.0K
17NSCNORFOLK SOUTHN CORPhistory →COM1.29%$4M15.3K
18TWOTWO HARBORS INVENTMENT CORPOhistory →COM1.09%$4M325.0K
19DAWNGBXDAY ONE BIOPHARMACEUTICALS Ihistory →COM1.05%$4M166.8K
20LWAYLIFEWAY FOODS INCCOM0.89%$3M157.5K
21VALARIS LTDCL A0.72%$2M25.0K
22RNAATRIUM THERAPEUTICS INCCOM0.71%$2M180.9K
23RKTROCKET COS INCCOM CL A0.32%$1M77.8K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$342M27May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$429M32Feb 13, 202613F-HRchanges · EDGAR ↗
Q3 2025$320M27Nov 13, 202513F-HRchanges · EDGAR ↗
Q2 2025$262M21Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$207M23May 13, 202513F-HRchanges · EDGAR ↗
Q4 2024$221M17Feb 12, 202513F-HRchanges · EDGAR ↗
Q3 2024$302M20Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$206M19Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$163M17May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$168M18Feb 14, 202413F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.